The vaccine has only been tested on 100 volunteers, the second drug to be rushed to production amid record-breaking virus spread
A survey found 13% of COVID-19 patients experienced hearing loss or tinnitus. For some, it could be permanent.
New lockdowns from China to Europe as virus trials stumble
World Bank approves $12 bln for Covid-19 vaccines
Vaccine reluctance linked to belief in virus hoaxes: study
Johnson & Johnson pauses Covid vaccine trial as participant becomes ill
Covid-19 reinfection casts doubt on virus immunity: study
Josiah Zayner, a former NASA scientist, replicated a COVID-19 vaccine that had worked in monkeys and tested it on himself. Zayner live-streamed the process over a couple of months and found that his experiment produced a promising result.
The MIND diet helps improve cognitive thinking and also lowers the risk and slows the progression of Alzheimer's.
Mask mandates become the norm in Iowa school districts after the state loosened restrictions.
The biotech is in a no-win situation.
Hong Kong performers long for the stage as pandemic drags on
Spanish capital rejects lockdown as Europe faces virus surge
The interim clinical data indicates that ID NOW flags infected patients in nearly every instance.
China's experimental vaccine tested 191 healthy participants and induced an immune response in candidates.
That's a slight delay from the companies' best-case scenarios.
US agency wants 2 months safety data before approving Covid-19 vaccine
The change would mandate two months of waiting to confirm safety and long-term immunity, but make delivery by the election almost impossible
Pfizer and BioNTech have assured the fast-track process will not compromise safety
The 3-year-old cocker spaniel died four days after being bitten on the chest.
Medical experts are concerned about the president's use of dexamethasone, a steroid normally reserved for more serious cases.
By timing the antimatter particles in PET scanners, a team of experts invented a device that could soon make cancer treatment less invasive.